Yasuhara O, Schwab C, Matsuo A, Kim S U, Steele J C, Akiguchi I, Kimura J, McGeer E G, McGeer P L
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver, Canada.
Neurosci Lett. 1996 Feb 23;205(2):107-10. doi: 10.1016/0304-3940(96)12385-5.
Midkine (MK) has been shown to be present in amyloid deposits in Alzheimer's disease (AD). In the present study, expression of midkine was examined immunohistochemically in brains of patients with the parkinsonism-dementia complex of Guam, lytico bodig disease (LB), using an affinity purified antibody to midkine. Positive staining was identified on some extracellular neurofibrillary tangles. The relative prevalence was somewhat less than for beta-amyloid protein (Abeta)-positive extracellular tangles. The results demonstrate that expression of MK and Abeta is not an exclusive feature of amyloid deposits in Alzheimer brain, but is also found in LB brain.
中期因子(MK)已被证明存在于阿尔茨海默病(AD)的淀粉样沉积物中。在本研究中,使用针对中期因子的亲和纯化抗体,通过免疫组织化学方法检测了关岛帕金森痴呆综合征(lytico bodig病,LB)患者大脑中中期因子的表达。在一些细胞外神经原纤维缠结上发现了阳性染色。其相对发生率略低于β淀粉样蛋白(Aβ)阳性的细胞外缠结。结果表明,MK和Aβ的表达并非阿尔茨海默病大脑淀粉样沉积物的独有特征,在LB病大脑中也有发现。